We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Appeal Tribunal judgment of Mrs Justice Eady on 20 May 2024.
How to use an interrupted time series to evaluate your digital health product.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
Using an ecological momentary assessment to evaluate your digital health product.
How to use an ethnographic study to evaluate your digital health product.
A keynote speech by Martin Coleman, Non-Executive Director and Panel Chair of the Competition and Markets Authority (CMA), to the Swedish Competition Authority’s Pros and Cons Conference.
How to use an N-of-1 study to evaluate your digital health product.
What qualifies as ordinary commuting and private travel for tax purposes.
How we investigate and what action we take on serious failures in landlords
How to use a before-and-after study to evaluate your digital health product.
Guidance on the use of Habitats Regulations Assessment
Check what processes are considered as insufficient production under the Trade and Cooperation Agreement.
Use these general provisions to help you determine the origin of your products.
How to use a randomised controlled trial to evaluate your digital health product.
Sir Martyn Oliver spoke about the Big Listen, the changes Ofsted is making and taking the time to collaboratively build a better education system for all.
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Guide to licensing procedure and other restrictions for export of controlled dual-use items, software and technology, goods for torture and radioactive sources.
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
Sets out special provisions for Crown development for dealing with security-sensitive information in planning applications.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).